Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab：A case report.

Hui GanLing WangWei FuJinjin ZhangMingxia YuGuanghui Liu

Published in: Journal of clinical pharmacy and therapeutics (2019)

Delayed hypersensitivity reactions to omalizumab are rare, but they may cause the interruption of drug usage. Desensitization to omalizumab could be a possible solution.

Keyphrases

drug induced
adverse drug